Polaris Partners is a renowned investment firm with over 25 years of experience in backing revolutionary healthcare and biotech companies. With a deep-rooted expertise in healthcare and science, Polaris Partners thrives on collaborating with groundbreaking innovators and repeat entrepreneurs. They are not just investors, but builders, with a team consisting of founders, inventors, and operators who possess 150+ years of investment experience.

Polaris Partners has an extensive network that spans over two decades, including prestigious companies, syndicate partners, universities, and research institutions. They have funded over 400 companies, with more than 100 successful exits and 50+ IPOs. Additionally, Polaris Partners has supported over 50 repeat entrepreneurs and helped launch over 50 therapies into the market.

Their portfolio focuses on healthcare and biotechnology, targeting innovative care delivery models, digital health, consumer-centric businesses, patient and provider solutions, and data science and analytics. They also prioritize life sciences and biotechnology companies that specialize in molecules and platforms, therapeutics, and genomics. In addition to their investment efforts, Polaris Partners has two affiliate funds: the Polaris Growth Fund, which supports the growth and expansion of profitable, founder-owned technology companies, and the Polaris Innovation Fund, which accelerates the commercial and therapeutic potential of early-stage academic research.

Polaris Partners operates in Boston, New York, and San Francisco, and they can be contacted through email or Twitter. Their commitment to excellence is reflected in their transformative potential and impactful outcomes